TY - JOUR AU - Checkley, M. A. AU - Luttge, B. G. AU - Freed, E. O. PY - 2011 DA - 2011// TI - HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation JO - J Mol Biol VL - 410 ID - Checkley2011 ER - TY - JOUR AU - Wyatt, R. AU - Sodroski, J. PY - 1998 DA - 1998// TI - The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens JO - Science VL - 280 ID - Wyatt1998 ER - TY - JOUR AU - Dalgleish, A. G. PY - 1984 DA - 1984// TI - The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus JO - Nature VL - 312 ID - Dalgleish1984 ER - TY - JOUR AU - Choe, H. PY - 1996 DA - 1996// TI - The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates JO - Cell VL - 85 ID - Choe1996 ER - TY - JOUR AU - Feng, Y. PY - 1996 DA - 1996// TI - HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor JO - Science VL - 272 ID - Feng1996 ER - TY - JOUR AU - DeVico, A. L. PY - 2007 DA - 2007// TI - CD4-induced epitopes in the HIV envelope glycoprotein, gp120 JO - Curr HIV Res VL - 5 ID - DeVico2007 ER - TY - JOUR AU - Finnegan, C. M. PY - 2001 DA - 2001// TI - Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion JO - J Virol VL - 75 ID - Finnegan2001 ER - TY - JOUR AU - Lewis, G. K. PY - 2014 DA - 2014// TI - Epitope target structures of Fc-mediated effector function during HIV-1 acquisition JO - Curr Opin HIV AIDS VL - 9 ID - Lewis2014 ER - TY - JOUR AU - Xiang, S. -. H. PY - 2002 DA - 2002// TI - Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies JO - AIDS Res Hum Retrovir VL - 18 ID - Xiang2002 ER - TY - JOUR AU - Veillette, M. PY - 2014 DA - 2014// TI - Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity JO - J Virol VL - 88 ID - Veillette2014 ER - TY - JOUR AU - Decker, J. M. PY - 2005 DA - 2005// TI - Antigenic conservation and immunogenicity of the HIV coreceptor binding site JO - J Exp Med VL - 201 ID - Decker2005 ER - TY - JOUR AU - Kwong, P. D. PY - 1998 DA - 1998// TI - Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody JO - Nature VL - 393 ID - Kwong1998 ER - TY - JOUR AU - Thali, M. PY - 1993 DA - 1993// TI - Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding JO - J Virol VL - 67 ID - Thali1993 ER - TY - JOUR AU - Wyatt, R. PY - 1998 DA - 1998// TI - The antigenic structure of the HIV gp120 envelope glycoprotein JO - Nature VL - 393 ID - Wyatt1998 ER - TY - JOUR AU - Guan, Y. PY - 2013 DA - 2013// TI - Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding JO - Proc Natl Acad Sci U S A VL - 110 ID - Guan2013 ER - TY - JOUR AU - Lewis, G. K. PY - 2017 DA - 2017// TI - Beyond viral neutralization JO - AIDS Res Hum Retrovir VL - 33 ID - Lewis2017 ER - TY - JOUR AU - Lewis, G. K. AU - Pazgier, M. AU - DeVico, A. L. PY - 2017 DA - 2017// TI - Survivors remorse: antibody-mediated protection against HIV-1 JO - Immunol Rev VL - 275 ID - Lewis2017 ER - TY - JOUR AU - Pollara, J. PY - 2013 DA - 2013// TI - Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses JO - Curr HIV Res VL - 11 ID - Pollara2013 ER - TY - JOUR AU - Richard, J. PY - 2016 DA - 2016// TI - Co-receptor binding site antibodies enable CD4-mimetics to expose conserved anti-cluster a ADCC epitopes on HIV-1 envelope glycoproteins JO - EBioMedicine VL - 12 ID - Richard2016 ER - TY - JOUR AU - Sullivan, N. PY - 1998 DA - 1998// TI - CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization JO - J Virol VL - 72 ID - Sullivan1998 ER - TY - JOUR AU - Shaik, M. M. PY - 2019 DA - 2019// TI - Structural basis of coreceptor recognition by HIV-1 envelope spike JO - Nature VL - 565 ID - Shaik2019 ER - TY - JOUR AU - DeVico, A. PY - 2007 DA - 2007// TI - Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens JO - Proc Natl Acad Sci U S A VL - 104 ID - DeVico2007 ER - TY - JOUR AU - Fouts, T. R. PY - 2015 DA - 2015// TI - Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection JO - Proc Natl Acad Sci U S A VL - 112 ID - Fouts2015 ER - TY - JOUR AU - Thomas, M. A. PY - 2014 DA - 2014// TI - HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques JO - Virology VL - 0 ID - Thomas2014 ER - TY - JOUR AU - Bonsignori, M. PY - 2012 DA - 2012// TI - Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family JO - J Virol VL - 86 ID - Bonsignori2012 ER - TY - JOUR AU - Pollara, J. PY - 2014 DA - 2014// TI - HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities JO - J Virol VL - 88 ID - Pollara2014 ER - TY - JOUR AU - Fouts, T. R. PY - 2000 DA - 2000// TI - Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex JO - J Virol VL - 74 ID - Fouts2000 ER - TY - JOUR AU - Prete, G. Q. PY - 2013 DA - 2013// TI - Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies JO - J Virol VL - 87 ID - Prete2013 ER - TY - JOUR AU - Scheid, J. F. PY - 2009 DA - 2009// TI - Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals JO - Nature VL - 458 ID - Scheid2009 ER - TY - JOUR AU - Xiang, S. -. H. PY - 2003 DA - 2003// TI - Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains JO - Virology VL - 315 ID - Xiang2003 ER - TY - JOUR AU - Choe, H. PY - 2003 DA - 2003// TI - Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120 JO - Cell VL - 114 ID - Choe2003 ER - TY - JOUR AU - Darbha, R. PY - 2004 DA - 2004// TI - Crystal structure of the broadly cross-reactive HIV-1-neutralizing fab X5 and fine mapping of its epitope JO - Biochemistry VL - 43 ID - Darbha2004 ER - TY - JOUR AU - Huang, C. -. C. PY - 2004 DA - 2004// TI - Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 JO - Proc Natl Acad Sci U S A VL - 101 ID - Huang2004 ER - TY - JOUR AU - Huang, C. -. C. PY - 2007 DA - 2007// TI - Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4 JO - Science (New York, N.Y.) VL - 317 ID - Huang2007 ER - TY - JOUR AU - Moulard, M. PY - 2002 DA - 2002// TI - Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120–CD4–CCR5 complexes JO - Proc Natl Acad Sci U S A VL - 99 ID - Moulard2002 ER - TY - JOUR AU - Farzan, M. PY - 1999 DA - 1999// TI - Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry JO - Cell VL - 96 ID - Farzan1999 ER - TY - JOUR AU - Alsahafi, N. PY - 2019 DA - 2019// TI - An asymmetric opening of HIV-1 envelope mediates antibody-dependent cellular cytotoxicity JO - Cell Host Microbe VL - 25 ID - Alsahafi2019 ER - TY - STD TI - Anand SP, Prévost J, Baril S, et al. Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells. J Virol. 2019;93(3):e01823-18. https://doi.org/10.1128/JVI.01823-18. ID - ref38 ER - TY - JOUR AU - Weiss, M. S. PY - 2001 DA - 2001// TI - Global indicators of X-ray data quality JO - J Appl Crystallogr VL - 34 ID - Weiss2001 ER - TY - JOUR AU - Karplus, P. A. AU - Diederichs, K. PY - 2012 DA - 2012// TI - Linking crystallographic model and data quality JO - Science VL - 336 ID - Karplus2012 ER - TY - JOUR AU - Brunger, A. T. PY - 1993 DA - 1993// TI - Assessment of phase accuracy by cross validation: the free R value. Methods and applications JO - Acta Crystallogr D Biol Crystallogr VL - 49 ID - Brunger1993 ER - TY - JOUR AU - Crooks, G. E. PY - 2004 DA - 2004// TI - WebLogo: a sequence logo generator JO - Genome Res VL - 14 ID - Crooks2004 ER - TY - JOUR AU - Liu, J. PY - 2008 DA - 2008// TI - Molecular architecture of native HIV-1 gp120 trimers JO - Nature VL - 455 ID - Liu2008 ER - TY - JOUR AU - Tran, E. E. PY - 2012 DA - 2012// TI - Structural mechanism of trimeric HIV-1 envelope glycoprotein activation JO - PLoS Pathog VL - 8 ID - Tran2012 ER - TY - JOUR AU - Harris, A. PY - 2011 DA - 2011// TI - Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures JO - Proc Natl Acad Sci U S A VL - 108 ID - Harris2011 ER - TY - JOUR AU - Wang, H. PY - 2016 DA - 2016// TI - Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop JO - Proc Natl Acad Sci U S A VL - 113 ID - Wang2016 ER - TY - JOUR AU - Sok, D. PY - 2016 DA - 2016// TI - A prominent site of antibody vulnerability on HIV envelope incorporates a motif associated with CCR5 binding and its camouflaging glycans JO - Immunity VL - 45 ID - Sok2016 ER - TY - JOUR AU - Orlandi, C. AU - Flinko, R. AU - Lewis, G. K. PY - 2016 DA - 2016// TI - A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies JO - J Immunol Methods VL - 433 ID - Orlandi2016 ER - TY - STD TI - Lee WS, Prévost J, Richard J, et al. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. J Virol. 2019;93(10):e01901-18. https://doi.org/10.1128/JVI.01901-18. ID - ref49 ER - TY - STD TI - Richard J, et al. Uninfected bystander cells impact the measurement of HIV-specific antibody-dependent cellular cytotoxicity responses. MBio. 2018;9(2). ID - ref50 ER - TY - JOUR AU - Veillette, M. PY - 2015 DA - 2015// TI - The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals JO - J Virol VL - 89 ID - Veillette2015 ER - TY - JOUR AU - Ding, S. PY - 2016 DA - 2016// TI - A highly conserved residue of the HIV-1 gp120 inner domain is important for antibody-dependent cellular cytotoxicity responses mediated by anti-cluster a antibodies JO - J Virol VL - 90 ID - Ding2016 ER - TY - JOUR AU - Richard, J. PY - 2014 DA - 2014// TI - Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses JO - J Virol Methods VL - 208 ID - Richard2014 ER - TY - JOUR AU - Bredow, B. PY - 2016 DA - 2016// TI - Comparison of antibody-dependent cell-mediated cytotoxicity and virus neutralization by HIV-1 Env-specific monoclonal antibodies JO - J Virol VL - 90 ID - Bredow2016 ER - TY - JOUR AU - Acharya, P. PY - 2014 DA - 2014// TI - Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection JO - J Virol VL - 88 ID - Acharya2014 ER - TY - STD TI - Tolbert WD, et al. Structural basis for epitopes in the gp120 cluster A region that invokes potent effector cell activity. Viruses. 2019;11(1). ID - ref56 ER - TY - JOUR AU - Richard, J. PY - 2018 DA - 2018// TI - Impact of HIV-1 envelope conformation on ADCC responses JO - Trends Microbiol VL - 26 ID - Richard2018 ER - TY - JOUR AU - Gohain, N. PY - 2015 DA - 2015// TI - Cocrystal structures of antibody N60-i3 and antibody JR4 in complex with gp120 define more cluster a epitopes involved in effective antibody-dependent effector function against HIV-1 JO - J Virol VL - 89 ID - Gohain2015 ER - TY - JOUR AU - Tolbert, W. D. PY - 2017 DA - 2017// TI - Targeting the late stage of HIV-1 entry for antibody-dependent cellular cytotoxicity: structural basis for Env epitopes in the C11 region JO - Structure VL - 25 ID - Tolbert2017 ER - TY - JOUR AU - Schnur, E. PY - 2011 DA - 2011// TI - The conformation and orientation of a 27-residue CCR5-peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide JO - J Mol Biol VL - 410 ID - Schnur2011 ER - TY - JOUR AU - Liu, X. PY - 2014 DA - 2014// TI - Site-selective solid-phase synthesis of a CCR5 Sulfopeptide library to interrogate HIV binding and entry JO - ACS Chem Biol VL - 9 ID - Liu2014 ER - TY - JOUR AU - Seibert, C. PY - 2002 DA - 2002// TI - Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence JO - Proc Natl Acad Sci U S A VL - 99 ID - Seibert2002 ER - TY - JOUR AU - Jen, C. H. AU - Moore, K. L. AU - Leary, J. A. PY - 2009 DA - 2009// TI - Pattern and temporal sequence of sulfation of CCR5 N-terminal peptides by tyrosylprotein sulfotransferase-2: an assessment of the effects of N-terminal residues JO - Biochemistry VL - 48 ID - Jen2009 ER - TY - JOUR AU - Richard, J. PY - 2015 DA - 2015// TI - CD4 mimetics sensitize HIV-1-infected cells to ADCC JO - Proc Natl Acad Sci VL - 112 ID - Richard2015 ER - TY - JOUR AU - Smith, S. A. PY - 2018 DA - 2018// TI - VH1-69 utilizing antibodies are capable of mediating non-neutralizing fc-mediated effector functions against the transmitted/founder gp120 JO - Front Immunol VL - 9 ID - Smith2018 ER - TY - JOUR AU - Acharya, P. PY - 2013 DA - 2013// TI - Structural basis for highly effective HIV-1 neutralization by CD4-mimetic miniproteins revealed by 1.5 A cocrystal structure of gp120 and M48U1 JO - Structure VL - 21 ID - Acharya2013 ER - TY - JOUR AU - McCoy, A. J. PY - 2007 DA - 2007// TI - Phaser crystallographic software JO - J Appl Crystallogr VL - 40 ID - McCoy2007 ER - TY - JOUR AU - Sanders, R. W. PY - 2002 DA - 2002// TI - Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1 JO - J Virol VL - 76 ID - Sanders2002 ER - TY - JOUR AU - Terwilliger, T. C. PY - 2008 DA - 2008// TI - Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard JO - Acta Crystallogr D Biol Crystallogr VL - 64 ID - Terwilliger2008 ER - TY - JOUR AU - Emsley, P. AU - Cowtan, K. PY - 2004 DA - 2004// TI - Coot: model-building tools for molecular graphics JO - Acta Crystallogr D Biol Crystallogr VL - 60 ID - Emsley2004 ER - TY - JOUR AU - Moore, J. P. PY - 1989 DA - 1989// TI - An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1 JO - Aids VL - 3 ID - Moore1989 ER - TY - JOUR AU - Ray, K. PY - 2014 DA - 2014// TI - Antigenic properties of the HIV envelope on virions in solution JO - J Virol VL - 88 ID - Ray2014 ER -